Goal and Learning Outcomes

Upon completion of this activity, participants should be better able to:

  • Describe current and emerging treatment options in mCSPC
  • Employ strategies for optimal management of treatment-related adverse events experienced by patients treated for mCSPC
  • Examine solutions for improving coordination and communication within the multidisciplinary cancer care team and with patients/caregivers to improve outcomes for patients with mCSPC


Archana Ajmera, MSN, ANP-BC, AOCNP

Advance Practice Provider Supervisor
Division of Hematology/Oncology
Genitourinary Oncology
UCSD Moores Cancer Center

Pedro Barata, MD, MSc

Assistant Professor
Deming Department of Medicine
Division of Hematology/Oncology
Genitourinary Cancers
Tulane University

Erik Castle, MD, FACS

Professor of Urology
Tulane University

Lisa M. Holle, PharmD, BCOP, FHOPA

Associate Clinical Professor of Pharmacy Practice
Department of Pharmacy Practice
UConn School of Pharmacy


Accreditation Information

This course is being provided by a Relias LLC strategic partner.  Consumption of this course will take place on the partners site and courses provided in this manner are not accredited by Relias LLC.